All Pharma News
Lexicon Pharmaceuticals to Host 2024 Investor Day

Lexicon Pharmaceuticals to Host 2024 Investor Day
GLOBENEWSWIRE
18 Apr 2024
Share Share
Lexicon to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Lexicon to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GLOBENEWSWIRE
03 Apr 2024
Share Share
Clinical Data on Impact of Sotagliflozin on StrokeHeart Attack Risk Four Lexicon

Clinical Data on Impact of Sotagliflozin on StrokeHeart Attack Risk Four Lexicon
GLOBENEWSWIRE
25 Mar 2024
Share Share
Lexicon preps FDA resubmission for diabetes hopeful Zynquista

Lexicon preps FDA resubmission for diabetes hopeful Zynquista
Zoey Becker FIERCE PHARMA
12 Mar 2024
Share Share
Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes

Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes
GLOBENEWSWIRE
11 Mar 2024
Share Share
Lexicon Announces $250 Million Private Placement of Equity Securities

Lexicon Announces $250 Million Private Placement of Equity Securities
GLOBENEWSWIRE
11 Mar 2024
Share Share
Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results

Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results
GLOBENEWSWIRE
11 Mar 2024
Share Share
Lexicon Pharmaceuticals Provides Business and Pipeline Update

Lexicon Pharmaceuticals Provides Business and Pipeline Update
GLOBENEWSWIRE
08 Jan 2024
Share Share
Lexicon To Participate In The 42nd Annual JPMorgan Healthcare Conference

Lexicon To Participate In The 42nd Annual JPMorgan Healthcare Conference
GLOBENEWSWIRE
21 Dec 2023
Share Share
Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211

Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211
GLOBENEWSWIRE
30 Nov 2023
Share Share